Waldenstrom Macroglobulinemia is Rare Disease Results of study are the most clinically relevant
Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Waldenstrom Macroglobulinemia is Rare Disease Results of study are the most clinically relevant at ASCO 2018
Author: Annual-Meeting
Added: 06/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Macroglobulinemia | Rare Diseases | Study | Waldenstrom's Macroglobulinemia